Japan Intellectual Property Rights: COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS

Japan, July 14 -- DECIBEL THERAPEUTICS INC,REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS.' Other related details are as follows:

Application Number: JP,2025-064211

Category (FI): A61K35/76,A61P27/16,C12N15/11@Z,A61K48/00,A61K38/17,C12N15/12,C12N15/864,100@Z

Stage: PROBLEM TO BE SOLVED: To provide compositions and methods for the treatment of sensorineural hearing loss and auditory neuropathy, particularly, forms of the disease that are associated with a mutation in otoferlin (OTOE), by way of OTOE gene therapy.SOLUTION: The disclosure provides a variety of compositions that include a first nucleic acid vector tha...